Published in Medical Devices and Surgical Technology Week, June 20th, 2004
For the 3 months ended March 31, 2004, the company recorded total revenues of $2,635,000 as compared to $1,693,000 for the comparable prior-year period, an increase of $942,000 or 56%.
The increase is attributable to revenue growth in the three core business units: prostate seeds, contract manufacturing, and government contracts. Revenue of the I-Plant prostate seed for the 3 months ended March 31, 2004, was approximately $853,000 as compared to $623,000 for the comparable prior-year period, an increase of $230,000 or 37%.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.